Explore

Trendline Trendline
Reflow Medical's Spur Elute Stent Shows Promising Six-Month Results in Coronary Study

Reflow Medical's Spur Elute Stent Shows Promising Six-Month Results in Coronary Study

Reflow Medical's Spur Elute Stent Shows Promising Six-Month Results in Coronary Study
Trendline Trendline
Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases

Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases

Qihan Biotech Receives FDA Clearance for Innovative CAR-T Therapy for Autoimmune Diseases
Trendline Trendline
Advita Ortho Introduces Equinoxe Scapula Reconstruction System for Complex Fractures

Advita Ortho Introduces Equinoxe Scapula Reconstruction System for Complex Fractures

Advita Ortho Introduces Equinoxe Scapula Reconstruction System for Complex Fractures
Trendline Trendline
Avvio Medical Introduces Innovative Ureteral Stone Treatment at AUA 2026

Avvio Medical Introduces Innovative Ureteral Stone Treatment at AUA 2026

Avvio Medical Introduces Innovative Ureteral Stone Treatment at AUA 2026
Trendline Trendline
Reflow Medical's Spur Elute Stent Shows Promising Results in Coronary Study

Reflow Medical's Spur Elute Stent Shows Promising Results in Coronary Study

Reflow Medical's Spur Elute Stent Shows Promising Results in Coronary Study
Trendline Trendline
Empirical Spine Launches LimiFlex as Motion-Preserving Alternative for Spinal Fusion in U.S.

Empirical Spine Launches LimiFlex as Motion-Preserving Alternative for Spinal Fusion in U.S.

Empirical Spine Launches LimiFlex as Motion-Preserving Alternative for Spinal Fusion in U.S.
Trendline Trendline
Poxel Reports Increased Revenue and Business Update for First Quarter 2026

Poxel Reports Increased Revenue and Business Update for First Quarter 2026

Poxel Reports Increased Revenue and Business Update for First Quarter 2026
Trendline Trendline
Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes, Aiming to Expand Treatment Options

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes, Aiming to Expand Treatment Options

Bayer Seeks FDA Approval for Kerendia in Type 1 Diabetes, Aiming to Expand Treatment Options
Trendline Trendline
Surescripts Expands Prior Authorization Automation to Improve Prescription Approval Times

Surescripts Expands Prior Authorization Automation to Improve Prescription Approval Times

Surescripts Expands Prior Authorization Automation to Improve Prescription Approval Times
Trendline Trendline
Catalent and Elpida Therapeutics Partner to Advance Gene Therapy for Rare Disease

Catalent and Elpida Therapeutics Partner to Advance Gene Therapy for Rare Disease

Catalent and Elpida Therapeutics Partner to Advance Gene Therapy for Rare Disease
Trendline Trendline
Widex Launches Allure AI RIC Hearing Aid with Enhanced Clarity and New Fitting Software

Widex Launches Allure AI RIC Hearing Aid with Enhanced Clarity and New Fitting Software

Widex Launches Allure AI RIC Hearing Aid with Enhanced Clarity and New Fitting Software
Trendline Trendline
Savara's Phase 3 Trial Shows Promise for Autoimmune Lung Disease Treatment

Savara's Phase 3 Trial Shows Promise for Autoimmune Lung Disease Treatment

Savara's Phase 3 Trial Shows Promise for Autoimmune Lung Disease Treatment